Rouprêt M - Search Results

1

Microsatellite instability and transitional cell carcinoma of the upper urinary tract.

Rouprêt M, Azzouzi AR, Cussenot O. Rouprêt M, et al. BJU Int. 2005 Sep;96(4):489-92. doi: 10.1111/j.1464-410X.2005.05671.x. BJU Int. 2005. PMID: 16104897 Review. No abstract available.

2

[Hereditary renal cell carcinoma: results and place of conventional conservative surgery].

Roupret M, Hupertan V, Chretien Y, Mejean A, Richard S, Chauveau D, Dufour B. Roupret M, et al. Prog Urol. 2003 Dec;13(6):1295-9. Prog Urol. 2003. PMID: 15000302 French.

3

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.

Roupret M, Catto J, Coulet F, Azzouzi AR, Amira N, Karmouni T, Fromont G, Sibony M, Vallancien G, Gattegno B, Meuth M, Hamdy FC, Cussenot O. Roupret M, et al. J Med Genet. 2004 Jul;41(7):e91. doi: 10.1136/jmg.2003.017871. J Med Genet. 2004. PMID: 15235034 Free PMC article. No abstract available.

4

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421

5

[Transitional cell carcinoma of the upper urinary tract new concepts in management].

Rouprêt M, Cussenot O. Rouprêt M, et al. Presse Med. 2005 Apr 23;34(8):601-7. doi: 10.1016/s0755-4982(05)83989-2. Presse Med. 2005. PMID: 15962502 Review. French.

6

Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma.

Rouprêt M, Coulet F, Azzouzi AR, Fromont G, Cussenot O. Rouprêt M, et al. BJU Int. 2005 Jul;96(1):149-51. doi: 10.1111/j.1464-410X.2005.05585.x. BJU Int. 2005. PMID: 15963139

7

Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O. Fromont G, et al. Among authors: roupret m. Eur Urol. 2005 Nov;48(5):764-70. doi: 10.1016/j.eururo.2005.07.005. Epub 2005 Aug 1. Eur Urol. 2005. PMID: 16126329

8

Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.

Rouprêt M, Fromont G, Bitker MO, Gattegno B, Vallancien G, Cussenot O. Rouprêt M, et al. Urology. 2006 May;67(5):1028-32. doi: 10.1016/j.urology.2005.11.035. Urology. 2006. PMID: 16698363

9

Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O. Rouprêt M, et al. Urology. 2006 Jun;67(6):1181-7. doi: 10.1016/j.urology.2005.12.034. Urology. 2006. PMID: 16765178

10

Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.

Rouprêt M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F, Cussenot O. Rouprêt M, et al. Eur Urol. 2007 Mar;51(3):709-13; discussion 714. doi: 10.1016/j.eururo.2006.07.019. Epub 2006 Jul 28. Eur Urol. 2007. PMID: 16911852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,069 results

Search Page

Filters